Loading...
•
Dec 31, 2023
TransMedics Q4 2023 Earnings Report
TransMedics reported a significant revenue increase and net income for Q4 2023.
Key Takeaways
TransMedics reported a 159% increase in revenue to $81.2 million for the fourth quarter of 2023, driven by increased utilization of the OCS through the National OCS Program (NOP) and the addition of TransMedics logistics services. The company generated a net income of $4.0 million, or $0.12 per share, compared to a net loss in the same quarter of the previous year.
Total revenue increased by 159% to $81.2 million compared to Q4 2022.
Net income was $4.0 million, or $0.12 per share, a significant improvement from the net loss in Q4 2022.
The increase in revenue was primarily due to increased utilization of the OCS through the National OCS Program (NOP) and additional revenue from TransMedics logistics services.
Gross margin was 59% compared to 66% in Q4 2022.
Revenue by Segment
Forward Guidance
TransMedics expects total revenue for full-year 2024 to be in the range of $360 million to $370 million, which represents 49% to 53% growth compared to the company’s prior year revenue.
Positive Outlook
- Total revenue for full-year 2024 to be in the range of $360 million to $370 million.
- Represents 49% to 53% growth compared to the company’s prior year revenue.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...